30.08.2024 aktualisiert
40 % verfügbar
Medical Writer
Pottenstein, Deutschland Dr. rer. nat.
Skills
Medical WriterMedical WritingScientific projects reviewScientific Writingmedical educationStudy Start-upStudy SummariesCongress ReportsScientific publicationsScientific abstractsScientific posters
I am your specialist for medical writing, review of medical and scientific documents, preparation and review of regulatory and ethics committee submissions, further clinical research documents, as well as scientific publications/abstracts/posters.
I work in clinical research since 2021, and am experienced with clinical study protocols, ICF, as well as further documents for clinical trials.
I look forward to hearing from you!
Recent publications:
- S.I. Bär, M. Gold et al. Guided Antitumoral Drugs: (Imidazol-2-ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L. Chemistry – A European Journal. Doi: 10.1002/chem.202005451.
- M. Gold et al. Monitoring circulating epithelial tumor cells (CETCs) in patients with locally advanced colorectal cancer during therapy as a tool to predict therapy response. Annals of Oncology, 31:S172.
- M. Gold et al. Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones. European Journal of Medicinal Chemistry, 189:112060.
- K. Dankhoff, M. Gold et al. Copper(II) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activity. Dalton Transactions, 48:15220.
- J.J. González et al. Luminescent Gold(I) Complexes of 1-Pyridinyl-3-anthracenyl-chalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects. Inorganic Chemistry, 58:12954.
- M. Gold et al. A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells. Journal of Biological Inorganic Chemistry, 24:647.
- F. Schmitt, M. Gold et al. New Naphthopyran analogues of LY290181 as potential tumor vascular-disrupting agents. European Journal of Medicinal Chemistry, 163:160.
- F. Schmitt, M. Gold et al. Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects. Bioorganic & Medicinal Chemistry, 25:4894.
I work in clinical research since 2021, and am experienced with clinical study protocols, ICF, as well as further documents for clinical trials.
I look forward to hearing from you!
Recent publications:
- S.I. Bär, M. Gold et al. Guided Antitumoral Drugs: (Imidazol-2-ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L. Chemistry – A European Journal. Doi: 10.1002/chem.202005451.
- M. Gold et al. Monitoring circulating epithelial tumor cells (CETCs) in patients with locally advanced colorectal cancer during therapy as a tool to predict therapy response. Annals of Oncology, 31:S172.
- M. Gold et al. Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones. European Journal of Medicinal Chemistry, 189:112060.
- K. Dankhoff, M. Gold et al. Copper(II) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activity. Dalton Transactions, 48:15220.
- J.J. González et al. Luminescent Gold(I) Complexes of 1-Pyridinyl-3-anthracenyl-chalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects. Inorganic Chemistry, 58:12954.
- M. Gold et al. A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells. Journal of Biological Inorganic Chemistry, 24:647.
- F. Schmitt, M. Gold et al. New Naphthopyran analogues of LY290181 as potential tumor vascular-disrupting agents. European Journal of Medicinal Chemistry, 163:160.
- F. Schmitt, M. Gold et al. Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects. Bioorganic & Medicinal Chemistry, 25:4894.
Sprachen
DeutschMutterspracheEnglischverhandlungssicher